SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING CAPACITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SUBTYPES OTHER THAN B - PHENOTYPIC AND GENOTYPIC CHARACTERISTICS

被引:149
作者
DEWOLF, F
HOGERVORST, E
GOUDSMIT, J
FENYO, EM
RUBSAMENWAIGMANN, H
HOLMES, H
GALVAOCASTRO, B
KARITA, E
WASI, C
SEMPALA, SDK
BAAN, E
ZORGDRAGER, F
LUKASHOV, V
OSMANOV, S
KUIKEN, C
CORNELISSEN, M
BELSEY, EM
HEYWARD, W
ESPARZA, J
VANDEPERRE, P
SEMPALA, S
TUGUME, B
BIRYAHWAHO, B
VONBRIESEN, H
ESSER, R
GREZ, M
NEWBERRY, A
RANJBAR, S
TOMLINSON, P
BRADAC, J
MCCUTCHAN, F
LOUWAGIE, J
HEGERICH, P
LOPEZGALINDEZ, C
OLIVARES, I
DOPAZO, J
MULLINS, JI
DELWART, EL
BACHMANN, HM
HAHN, BH
GAO, F
YUE, L
SARAGOSTI, S
SCHOCHETMAN, G
KALISH, M
LUO, CC
GEORGE, R
PAU, CP
WEBER, J
CHEINGSONGPOPOV, R
机构
[1] KAROLINSKA INST,DEPT MICROBIOL & TUMORBIOL,STOCKHOLM,SWEDEN
[2] BAYER AG,ZENTRUM PHARMAFORSCH,INST VIROL,W-5600 WUPPERTAL,GERMANY
[3] CHEMOTHERAPEUT FORSCHUNGSINST GEORG SPEYER HAUS,FRANKFURT,GERMANY
[4] NATL INST BIOL STAND & CONTROLS,POTTERS BAR EN6 3QG,HERTS,ENGLAND
[5] BRAZILIAN NETWORK HIV ISOLAT & CHARACTERIZAT,REFERENCE LAB,SALVADOR,BA,BRAZIL
[6] NATL AIDS CONTROL PROGRAMME,REFERENCE LAB,KIGALI,RWANDA
[7] MAHIDOL UNIV,SIRIRAJ HOSP,FAC MED,DIV VIROL,BANGKOK 10700,THAILAND
[8] UGANDA VIRUS RES INST,ENTEBBE,UGANDA
[9] WHO,GLOBAL PROGRAMME AIDS,WHO NETWORK HIV ISOLAT & CHARACT,VACCINE DEV UNIT,CH-1211 GENEVA,SWITZERLAND
[10] NATL INST BIOL STAND & CONTROLS,LONDON NW3 6RB,ENGLAND
[11] NIAID,DIV AIDS,BETHESDA,MD 20892
[12] WALTER REED ARMY INST RES,HENRY M JACKSON FDN RES LAB,ROCKVILLE,MD
[13] INST SALUD CARLOS 3,CTR NACL BIOL CELULAR & RETROVIRUS,MADRID,SPAIN
[14] STANFORD UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305
[15] UNIV AMSTERDAM,HUMAN RETROVIRUS LAB,AMSTERDAM,NETHERLANDS
[16] UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35294
[17] INST COCHIN GENET MOLEC,F-75014 PARIS,FRANCE
[18] CTR DIS CONTROL & PREVENT,ATLANTA,GA 30341
[19] ST MARYS HOSP,SCH MED,LONDON,ENGLAND
[20] NCI,VIROL BIOL UNIT,FREDERICK,MD 21701
[21] KAROLINSKA INST,STOCKHOLM,SWEDEN
[22] SWEDISH INST INFECT DIS CONTROL,STOCKHOLM,SWEDEN
[23] LOS ALAMOS NATL LAB,LOS ALAMOS,NM
关键词
D O I
10.1089/aid.1994.10.1387
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Positively charged amino acid substitutions at positions 11 and 25 within the loop of the third variable region (V3) of HIV-1 subtype B envelope have been shown to be associated with the syncytium-inducing (SI) phenotype of the virus. The present study was designed to examine SI and NSI-associated V3 mutations in HIV-1 subtypes other than B. HIV-1 RNA was isolated from 53 virus stocks and 26 homologous plasma samples from 53 recently infected individuals from Brazil, Rwanda, Thailand, and Uganda. The C2-V3 region of the viral envelope was converted to cDNA, amplified, and sequenced. Of 53 primary virus stock samples 49 were biologically phenotyped through measurement of the syncytium-inducing capacity in MT-2 cells (to differentiate between SI and NSI phenotypes). In addition, after passage of primary isolates through PHA stimulated donor PBMC, the replication capacity was determined in U937-2, CEM, MT-2, and Jurkat-tat cell lines (to differentiate rapid/high and slow/low phenotypes). According to the sequence analysis 9 (17.0%) of the viruses belonged to subtype A, 15 (28.3%) to subtype B, 1 (1.9%) to subtype C, 13 (24.5%) to subtype D, and 15 (28.3%) to subtype E. Sequence analysis of virus RNA, obtained from 26 homologous plasma samples, confirmed the homogeneity of sequence populations in plasma compared to primary virus isolates. Of the 49 viruses tested 12 had the SI phenotype, 5 were confirmed to be rapid/high, and 4 appeared to be slow/low pattern 3 replicating. Of 49, 29 had the NSI phenotype, 24 were confirmed to be slow/low pattern 1 or 2, and 3 appeared to be slow/low pattern 3 replicating. Analysis of mutations at V3 loop amino acid positions 11 and 25 revealed that 10/12 (83.3%) of the SI viruses had SI-associated V3 mutations and that 28/29 (96.6%) of the NSI viruses lacked these mutations. V3 loop heterogeneity, length polymorphism, and a high number of positively charged amino acid substitutions were most frequently found among subtype D variants. These results indicate that both the phenotypic distinction between SI and NSI viruses and the association of biological phenotype with V3 mutations is present among HIV-1 subtypes other than B.
引用
收藏
页码:1387 / 1400
页数:14
相关论文
共 82 条
  • [1] UGANDAN HIV-1 V3 LOOP SEQUENCES CLOSELY RELATED TO THE UNITED-STATES EUROPEAN CONSENSUS
    ALBERT, J
    FRANZEN, L
    JANSSON, M
    SCARLATTI, G
    KATAAHA, PK
    KATABIRA, E
    MUBIRO, F
    RYDAKER, M
    ROSSI, P
    PETTERSSON, U
    WIGZELL, H
    [J]. VIROLOGY, 1992, 190 (02) : 674 - 681
  • [2] BOTH THE V2 AND V3 REGIONS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SURFACE GLYCOPROTEIN FUNCTIONALLY INTERACT WITH OTHER ENVELOPE REGIONS IN SYNCYTIUM FORMATION
    ANDEWEG, AC
    LEEFLANG, P
    OSTERHAUS, ADME
    BOSCH, ML
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (06) : 3232 - 3239
  • [3] ASJO B, 1986, LANCET, V2, P660
  • [4] SUSCEPTIBILITY TO INFECTION BY THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) CORRELATES WITH T4 EXPRESSION IN A PARENTAL MONOCYTOID CELL-LINE AND ITS SUBCLONES
    ASJO, B
    IVHED, I
    GIDLUND, M
    FUERSTENBERG, S
    FENYO, EM
    NILSSON, K
    WIGZELL, H
    [J]. VIROLOGY, 1987, 157 (02) : 359 - 365
  • [5] RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS
    BOOM, R
    SOL, CJA
    SALIMANS, MMM
    JANSEN, CL
    WERTHEIMVANDILLEN, PME
    VANDERNOORDAA, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) : 495 - 503
  • [6] THE REGION OF THE ENVELOPE GENE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESPONSIBLE FOR DETERMINATION OF CELL TROPISM
    CANN, AJ
    CHURCHER, MJ
    BOYD, M
    OBRIEN, W
    ZHAO, JQ
    ZACK, J
    CHEN, ISY
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (01) : 305 - 309
  • [7] IDENTIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GENE-SEQUENCES INFLUENCING VIRAL ENTRY INTO CD4-POSITIVE HELA-CELLS, T-LEUKEMIA CELLS, AND MACROPHAGES
    CHESEBRO, B
    NISHIO, J
    PERRYMAN, S
    CANN, A
    OBRIEN, W
    CHEN, ISY
    WEHRLY, K
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (11) : 5782 - 5789
  • [8] MACROPHAGE-TROPIC HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATES FROM DIFFERENT PATIENTS EXHIBIT UNUSUAL V3 ENVELOPE SEQUENCE HOMOGENEITY IN COMPARISON WITH T-CELL-TROPIC ISOLATES - DEFINITION OF CRITICAL AMINO-ACIDS INVOLVED IN CELL TROPISM
    CHESEBRO, B
    WEHRLY, K
    NISHIO, J
    PERRYMAN, S
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (11) : 6547 - 6554
  • [9] DETECTION OF 3 DISTINCT PATTERNS OF T-HELPER CELL DYSFUNCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS - INDEPENDENCE OF CD4+ CELL NUMBERS AND CLINICAL STAGING
    CLERICI, M
    STOCKS, NI
    ZAJAC, RA
    BOSWELL, RN
    LUCEY, DR
    VIA, CS
    SHEARER, GM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) : 1892 - 1899
  • [10] CLERICI M, 1991, J IMMUNOL, V146, P2214